3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
13
Pancreatic Neoplasms
6
Breast Neoplasms
6
Ovarian Neoplasms
4
Uterine Cervical Neoplasms
3
Multiple Myeloma
3
Melanoma
3
Lymphoma
3
Thyroid Diseases
2
Prostatic Neoplasms
2
Pancreatic Cyst
2
Neoplasm Metastasis
2
Myasthenia Gravis
2
Mesothelioma, Malignant
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Neoplasms
2
Endometrial Neoplasms
2
Wilms Tumor
1
Venous Thrombosis
1
Venous Thromboembolism
1
Uveal Melanoma
1
Uterine Cervical Dysplasia
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Thrombosis
1
Testicular Neoplasms
1
Interventions
fludarabine
2
Cyclophosphamide
2
ublituximab
1
thymoglobulin
1
prednylidene
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Sugars
1
Rituximab
1
Prednisone
1
Peripheral Blood Stem Cell Transplantation
1
Mitoxantrone
1
Melphalan
1
LFB-R603
1
Immunoglobulins, Intravenous
1
Etoposide
1
Data Collection
1
Cytarabine
1
Carmustine
1
Antilymphocyte Serum
1
Alleles
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neuromyelitis Optica
×
Data Collection
×
Clear all
NCT06443333
2024-06-05
NIDBase
Xuanwu Hospital, Beijing
Unknown
7,000 enrolled